{
    "analytics_identifier":  null,
    "base_path":  "/guidance/completed-paediatric-studies-submission-processing-and-assessment-in-the-event-of-a-no-deal-scenario",
    "content_id":  "e2907550-e230-45d4-a988-61a4b049be72",
    "description":  "Guidance on the submission, processing and assessment of all completed paediatric studies sponsored by Marketing Authorisation Holders (MAHs) in a no-deal Brexit.",
    "details":  {
                    "attachments":  [
                                        {
                                            "accessible":  false,
                                            "alternative_format_contact_email":  "webupdates@mhra.gov.uk",
                                            "attachment_type":  "file",
                                            "content_type":  "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
                                            "file_size":  31712,
                                            "filename":  "Suggested_MAH_cover_letter.docx",
                                            "id":  "4018419",
                                            "title":  "(suggested cover letter template)",
                                            "url":  "https://assets.publishing.service.gov.uk/media/5d9f5923e5274a595fe1fa3d/Suggested_MAH_cover_letter.docx"
                                        }
                                    ],
                    "body":  "\u003cdiv class=\"govspeak\"\u003e\n\u003cp\u003eThis guidance will apply from exit day in line with the \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/uksi/2019/775/contents/made\" class=\"govuk-link\"\u003eHuman Medicines Regulations (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003ch2 id=\"legal-background-and-scope\"\u003eLegal background and scope\u003c/h2\u003e\n\n\u003cp\u003e\u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/ukdsi/2019/9780111179185/part/5?view=plain\" class=\"govuk-link\"\u003eRegulation 78A(13) and (14) of the Human Medicines Regulations 2012, as amended by the Human Medicines (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e, requires that holders of a UK marketing authorisation who sponsor a study which involves use in the paediatric population in respect of the medicinal product to which that authorisation relates must submit to the Medicines and Healthcare products Regulatory Agency (\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e) results of the study within the period of six months beginning with the day on which the trial ended.\u003c/p\u003e\n\n\u003cp\u003eThis applies irrespective of whether or not:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cp\u003ethe studies are conducted in accordance with an agreed paediatric investigation plan (\u003cabbr title=\"paediatric investigation plan\"\u003ePIP\u003c/abbr\u003e); or\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003ethe \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e intends to apply for a marketing authorisation for a paediatric indication in relation to the product.\u003c/p\u003e\n  \u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eThese provisions replace Article 46 of Regulation (EC) No 1901/2006 (the ‘Paediatric Regulation’).\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will also consider the outcome of \u003cabbr title=\"Coordination Group for Mutual Recognition and Decentralised Procedures - Human\"\u003eCMDh\u003c/abbr\u003e paediatric work-sharing procedures (\u003cabbr title=\"paediatric work-sharing procedures\"\u003ePdWS\u003c/abbr\u003e) reviewed under Article 45 of Regulation (EC) No 1901/2006 (as amended). If required, \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will request updates to the product information (\u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e) for UK Marketing Authorisations.\u003c/p\u003e\n\n\u003ch2 id=\"submission-of-information\"\u003e1. Submission of information\u003c/h2\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e needs to submit a cover letter \u003ca rel=\"external\" href=\"https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/785033/Annex_I_-_Suggested_MAH_cover_letter_template.docx\" class=\"govuk-link\"\u003e(suggested cover letter template)\u003c/a\u003e (MS Word Document, 29.3KB) within 6 months of completion (i.e. date of last visit of last subject undergoing the trial, unless otherwise justified in the protocol) of the concerned paediatric studies to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e in eCTD format to this mailbox: \u003ca href=\"mailto:paediatricstudies@mhra.gov.uk\" class=\"govuk-link\"\u003epaediatricstudies@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should indicate in the cover letter whether the study(ies):\u003c/p\u003e\n\n\u003cp\u003e1.1. are linked to other paediatric studies which have been or will be the subject of other submissions under \u003ca rel=\"external\" href=\"http://www.legislation.gov.uk/ukdsi/2019/9780111179185/part/5?view=plain\" class=\"govuk-link\"\u003eRegulation 78A of the Human Medicines Regulations 2012, as amended by the Human Medicines (Amendment etc.) (\u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Exit) Regulations 2019\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003eIf this is the case, the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should provide the study title(s) with approximate date of completion. If the study(ies) relate to a UK \u003cabbr title=\"paediatric investigation plan\"\u003ePIP\u003c/abbr\u003e, the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should provide the \u003cabbr title=\"paediatric investigation plan\"\u003ePIP\u003c/abbr\u003e number.\u003c/p\u003e\n\n\u003cp\u003e1.2. have been or will be submitted in the UK as part of a variation/extension or any other application including this paediatric study. If this is the case, the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cp\u003especify the UK procedure number, if available or the type of application this will be submitted under\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003econfirm that the application will be submitted within the next 6 months\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003econfirm that, based on the results of the study, no urgent safety update of the product information is required\u003c/p\u003e\n  \u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should provide any relevant information about any related Article 46 of Regulation (EC) No 1901/2006 procedure(s) or \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e agreed \u003cabbr title=\"paediatric investigation plan\"\u003ePIP\u003c/abbr\u003e(s).\u003c/p\u003e\n\n\u003cp\u003eThe \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e should also state whether as a result of the paediatric study there is a need to update the product information.\u003c/p\u003e\n\n\u003ch2 id=\"initial-appraisal\"\u003e2. Initial appraisal\u003c/h2\u003e\n\n\u003cp\u003eOn receipt of the cover letter, \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will carry out an initial appraisal of whether an assessment procedure is required at this stage. One of the following may apply:\u003c/p\u003e\n\n\u003cp\u003e2.1. Assessment of the data is not required at this stage and \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will maintain records including justification for the decision, e.g. that a regulatory submission to vary the Marketing Authorisation is planned in the next 6 months, or any other agreed reason(s) to defer the procedure.\u003c/p\u003e\n\n\u003cp\u003e2.2. Limited evaluation of the study data may be undertaken if the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e provides robust justification that the study data are unlikely to warrant product information (\u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e) changes. The \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e will need to state in the cover letter that one or more of the following criteria are met:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003ethe same data have been reviewed in another regulatory procedure by \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e or another competent authority and the review has not led to \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes\u003c/li\u003e\n  \u003cli\u003ethe study was conducted mainly in adult patients with limited paediatric patients included\u003c/li\u003e\n  \u003cli\u003ethe drug is already licensed in the paediatric population and the study does not provide new \u003cabbr title=\"Pharmacokinetic\"\u003ePK\u003c/abbr\u003e, efficacy or safety data\u003c/li\u003e\n  \u003cli\u003ethe study, due to its design, limited number of paediatric patients, discontinuation or other reason does not allow drawing conclusions on efficacy or safety that would impact on the drug’s benefit:risk ratio or be useful to prescribers and patients\u003c/li\u003e\n  \u003cli\u003eonly interim results from an ongoing study are available which will be assessed later in their totality\u003c/li\u003e\n  \u003cli\u003ethe study has been conducted in populations and/or diseases that are not applicable to UK (for example hay fever to specific seasonal pollen found in non-UK countries)\u003c/li\u003e\n  \u003cli\u003eother justification as to why a detailed assessment is not required at this stage\u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eIf one or more of the above criteria are met, the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should submit the study report and a short clinical overview (as in 2.3) including justification why \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes are not necessary. A variation application will not be requested if \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e agrees with the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e’s justification not to update the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e.\u003c/p\u003e\n\n\u003cp\u003e2.3. If review of the data is required when the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e proposes a \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e update or when \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e concludes after the initial appraisal, that a full assessment is needed to robustly conclude on prospective \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e updates, \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will notify the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e to submit the paediatric data within 60 days as a type II variation application (change code C.I.13 - complex type II variations fees will be applicable). The \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e should submit the following:\u003c/p\u003e\n\n\u003cul\u003e\n  \u003cli\u003e\n    \u003cp\u003eFinal clinical study report\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eA short clinical overview clarifying the context of the data, including information on the pharmaceutical formulation used in the study, the existence of a suitable paediatric formulation and if relevant, conditions for an extemporaneous formulation.\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eA summary of Product Characteristics/ Patient Leaflet (\u003cabbr title=\"Summary of product characteristics\"\u003eSmPC\u003c/abbr\u003e/PL) proposal to update the paediatric information, or when none is considered required, justification that changes are not necessary.\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eFor a paediatric study that is part of a development program including a \u003cabbr title=\"paediatric investigation plan\"\u003ePIP\u003c/abbr\u003e, a line listing of all relevant studies.\u003c/p\u003e\n  \u003c/li\u003e\n  \u003cli\u003e\n    \u003cp\u003eIf the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e holds other paediatric studies for the same active substance falling under the scope of \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Article 45 of Regulation (EC) No 1901/2006 which have not yet been assessed by a competent authority, these should be submitted along with a clinical overview clarifying the context of the data.\u003c/p\u003e\n  \u003c/li\u003e\n\u003c/ul\u003e\n\n\u003cp\u003eIf the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e is unable to submit the type II variation within the 60-day timeframe, they must justify the delay and propose a new submission date.\u003c/p\u003e\n\n\u003ch2 id=\"transitional-provisions\"\u003e3. Transitional provisions\u003c/h2\u003e\n\n\u003cp\u003eIf the results of a paediatric study have been submitted to \u003cabbr title=\"European Medicines Agency\"\u003eEMA\u003c/abbr\u003e or \u003cabbr title=\"Coordination Group for Mutual Recognition and Decentralised Procedures - Human\"\u003eCMDh\u003c/abbr\u003e under Article 46 of Regulation (EC) 1901/2006 prior to exit day, the process will remain within the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e assessment framework and no UK equivalent procedure will be initiated unless the \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e indicates that an urgent safety update of the product information (\u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e) is required.\u003c/p\u003e\n\n\u003cp\u003eUpon finalisation of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e procedure and availability of the final assessment report, \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e should submit this to \u003ca href=\"mailto:paediatricstudies@mhra.gov.uk\" class=\"govuk-link\"\u003epaediatricstudies@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will check the applicability of the outcome of the \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e procedure for UK products. If there are proposed changes to the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e which can be directly implemented to relevant UK products, if not already submitted, \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will request \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e to submit a Type IB variation to update the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e within 60 days.\u003c/p\u003e\n\n\u003ch2 id=\"workflow-steps-for-submission-and-assessment-of-mah-sponsored-paediatric-studies\"\u003eWorkflow steps for submission and assessment of \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e sponsored paediatric studies\u003c/h2\u003e\n\n\u003ctable\u003e\n  \u003cthead\u003e\n    \u003ctr\u003e\n      \u003cth scope=\"col\"\u003eSteps\u003c/th\u003e\n      \u003cth scope=\"col\"\u003eDay\u003c/th\u003e\n      \u003cth scope=\"col\"\u003eAction\u003c/th\u003e\n    \u003c/tr\u003e\n  \u003c/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e1\u003c/td\u003e\n      \u003ctd\u003e0\u003c/td\u003e\n      \u003ctd\u003eReceipt of letter notifying \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e of completed study from \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e (see suggested template) via \u003ca href=\"mailto:paediatricstudies@mhra.gov.uk\" class=\"govuk-link\"\u003epaediatricstudies@mhra.gov.uk\u003c/a\u003e\n\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e2\u003c/td\u003e\n      \u003ctd\u003e7\u003c/td\u003e\n      \u003ctd\u003eAllocate procedure to medical assessor\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e3\u003c/td\u003e\n      \u003ctd\u003e14\u003c/td\u003e\n      \u003ctd\u003eInform \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e whether assessment of the data is required: A). If required, a variation is requested within 60 days, details of a submission package is described in section 2.3 of Submission of information, go to step 4, B). If an \u003cabbr title=\"European Medicines Agency\"\u003eEMA\u003c/abbr\u003e P46 or \u003cabbr title=\"Coordination Group for Mutual Recognition and Decentralised Procedures - Human\"\u003eCMDh\u003c/abbr\u003e \u003cabbr title=\"paediatric work-sharing procedures\"\u003ePdWS\u003c/abbr\u003e under Article 46 of Reg.1901/2006 has been completed prior exit day and \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes is a direct implementation to relevant UK products, step 11, C). If not required, \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e will be informed that no further action is needed\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e4\u003c/td\u003e\n      \u003ctd\u003e-14\u003c/td\u003e\n      \u003ctd\u003e\n\u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e submits data as variation type II, followed by Validation process (up to 14 calendar days)\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e5\u003c/td\u003e\n      \u003ctd\u003eClock starts: 0\u003c/td\u003e\n      \u003ctd\u003eProvide \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e with start date of procedure\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e6\u003c/td\u003e\n      \u003ctd\u003eStandard: 59/60 (in exceptional circumstances for Extended: 89/90)\u003c/td\u003e\n      \u003ctd\u003ePreliminary \u003cabbr title=\"Assessment Report\"\u003eAR\u003c/abbr\u003e followed by clock-stop period if there is a need for \u003cabbr title=\"Request for Further Information\"\u003eRFI\u003c/abbr\u003e or  Preliminary/Final \u003cabbr title=\"Assessment Report\"\u003eAR\u003c/abbr\u003e, where changes to the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e could be implemented at the end of the procedure if applicable\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e7\u003c/td\u003e\n      \u003ctd\u003eClock-stop\u003c/td\u003e\n      \u003ctd\u003eClock-stop period should not be longer than 60 days for responses + 60 days for assessment of the responses (extension of clock-stop period could be considered upon request)\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e8\u003c/td\u003e\n      \u003ctd\u003eStandard: 60 (Extended: 90)\u003c/td\u003e\n      \u003ctd\u003eFinal \u003cabbr title=\"Assessment Report\"\u003eAR\u003c/abbr\u003e sent to \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e, where changes to the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e could be implemented at the end of procedure if applicable\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e9\u003c/td\u003e\n      \u003ctd\u003eStandard: 75 (Extended: 105)\u003c/td\u003e\n      \u003ctd\u003eDraft Public paediatric \u003cabbr title=\"Assessment Report\"\u003eAR\u003c/abbr\u003e sent to \u003cabbr title=\"Marketing Authorisation Holder\"\u003eMAH\u003c/abbr\u003e to comment on any confidential/commercial sensitive information within 15 days\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e10\u003c/td\u003e\n      \u003ctd\u003eStandard: 90 (Extended: 120)\u003c/td\u003e\n      \u003ctd\u003ePublish Public paediatric \u003cabbr title=\"Assessment Report\"\u003eAR\u003c/abbr\u003e on \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e website\u003c/td\u003e\n    \u003c/tr\u003e\n    \u003ctr\u003e\n      \u003ctd\u003e11\u003c/td\u003e\n      \u003ctd\u003e60\u003c/td\u003e\n      \u003ctd\u003eIf step \u0026lt;3b\u0026gt; is applicable, request will be sent to \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e for type IB variations submission, to update the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e within 60 days\u003c/td\u003e\n    \u003c/tr\u003e\n  \u003c/tbody\u003e\n\u003c/table\u003e\n\n\u003ch2 id=\"processing-and-assessment-of-outcome-of-eu-article-45-work-sharing-procedures\"\u003eProcessing and assessment of outcome of \u003cabbr title=\"European Union\"\u003eEU\u003c/abbr\u003e Article 45 work sharing procedures\u003c/h2\u003e\n\n\u003cp\u003e\u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e are not required to submit to the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e information on paediatric studies completed by 26 January 2007 and which fall under the remit of Article 45 of Regulation (EC) No 1901/2006 work sharing procedure.\u003c/p\u003e\n\n\u003cp\u003e\u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will monitor the published Public Assessment Reports (\u003cabbr title=\"Public Assessment Report\"\u003ePAR\u003c/abbr\u003e) of Article 45 \u003cabbr title=\"paediatric work-sharing procedures\"\u003ePdWS\u003c/abbr\u003e procedures. Once a new \u003cabbr title=\"Public Assessment Report\"\u003ePAR\u003c/abbr\u003e is identified, any proposed (\u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e) changes and their applicability for UK products with the same active substance will be reviewed.\u003c/p\u003e\n\n\u003col\u003e\n  \u003cli\u003eIf products with the same active substance are not available in the UK or the \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes proposed are not applicable to UK products, no further action will be taken.\u003c/li\u003e\n  \u003cli\u003eIf the proposed \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes are directly applicable to UK products, if not already submitted, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e will send a request to the UK \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e to submit a type IB variation within 60 days.\u003c/li\u003e\n  \u003cli\u003eIf proposed \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes are not directly applicable to the UK products, the \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e may adapt the recommendations and subsequently send requests to UK \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e for type IB variation, where the UK adapted recommendations will be provided, within 60 days.\u003c/li\u003e\n  \u003cli\u003eIf \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e considers that the \u003cabbr title=\"Marketing Authorisation Holders\"\u003eMAHs\u003c/abbr\u003e should provide supplementary data in order to conclude on potential \u003cabbr title=\"product information\"\u003ePI\u003c/abbr\u003e changes for the UK products and further UK assessment is deemed necessary, a type II variation could be requested within 60 days.\u003c/li\u003e\n\u003c/ol\u003e\n\n\u003ch2 id=\"contact-mhra\"\u003eContact \u003cabbr title=\"Medicines and Healthcare products Regulatory Agency\"\u003eMHRA\u003c/abbr\u003e\n\u003c/h2\u003e\n\u003cp\u003ePlease direct any queries to \u003ca href=\"mailto:specialpopulationsunit@mhra.gov.uk\" class=\"govuk-link\"\u003especialpopulationsunit@mhra.gov.uk\u003c/a\u003e.\u003c/p\u003e\n\n\u003c/div\u003e",
                    "change_history":  [
                                           {
                                               "note":  "Added new information (section 2.2). This covers the criteria Marketing Authorisation Holders will need to meet if only limited evaluation of the study data is to take place. ",
                                               "public_timestamp":  "2019-10-09T16:11:01.000+01:00"
                                           },
                                           {
                                               "note":  "Change of text within Stay up to date box.",
                                               "public_timestamp":  "2019-10-09T12:34:58.000+01:00"
                                           },
                                           {
                                               "note":  "Removed some outdated background content.",
                                               "public_timestamp":  "2019-08-08T14:51:47.000+01:00"
                                           },
                                           {
                                               "note":  "First published.",
                                               "public_timestamp":  "2019-03-11T15:04:00.000+00:00"
                                           }
                                       ],
                    "emphasised_organisations":  [
                                                     "240f72bd-9a4d-4f39-94d9-77235cadde8e"
                                                 ],
                    "first_public_at":  "2019-03-11T15:04:00.000+00:00",
                    "political":  false,
                    "related_mainstream_content":  [

                                                   ],
                    "tags":  {
                                 "browse_pages":  [

                                                  ]
                             }
                },
    "document_type":  "detailed_guide",
    "first_published_at":  "2019-03-11T15:04:00+00:00",
    "links":  {
                  "available_translations":  [
                                                 {
                                                     "api_path":  "/api/content/guidance/completed-paediatric-studies-submission-processing-and-assessment-in-the-event-of-a-no-deal-scenario",
                                                     "api_url":  "https://www.gov.uk/api/content/guidance/completed-paediatric-studies-submission-processing-and-assessment-in-the-event-of-a-no-deal-scenario",
                                                     "base_path":  "/guidance/completed-paediatric-studies-submission-processing-and-assessment-in-the-event-of-a-no-deal-scenario",
                                                     "content_id":  "e2907550-e230-45d4-a988-61a4b049be72",
                                                     "document_type":  "detailed_guide",
                                                     "links":  {

                                                               },
                                                     "locale":  "en",
                                                     "public_updated_at":  "2019-10-09T15:11:01Z",
                                                     "schema_name":  "detailed_guide",
                                                     "title":  "Completed Paediatric Studies - submission, processing and assessment in a no-deal Brexit",
                                                     "web_url":  "https://www.gov.uk/guidance/completed-paediatric-studies-submission-processing-and-assessment-in-the-event-of-a-no-deal-scenario",
                                                     "withdrawn":  true
                                                 }
                                             ],
                  "facet_groups":  [
                                       {
                                           "content_id":  "52435175-82ed-4a04-adef-74c0199d0f46",
                                           "document_type":  "facet_group",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:54Z",
                                           "schema_name":  "facet_group",
                                           "title":  "Find EU Exit guidance business",
                                           "withdrawn":  false
                                       }
                                   ],
                  "facet_values":  [
                                       {
                                           "content_id":  "93f5c156-2449-4e52-9e92-aefc73586ffd",
                                           "document_type":  "facet_value",
                                           "links":  {

                                                     },
                                           "locale":  "en",
                                           "public_updated_at":  "2019-04-16T08:46:58Z",
                                           "schema_name":  "facet_value",
                                           "title":  "Pharmaceuticals and clinical trials",
                                           "withdrawn":  false
                                       }
                                   ],
                  "government":  [
                                     {
                                         "api_path":  "/api/content/government/2015-conservative-government",
                                         "api_url":  "https://www.gov.uk/api/content/government/2015-conservative-government",
                                         "base_path":  "/government/2015-conservative-government",
                                         "content_id":  "d4fbc1b9-d47d-4386-af04-ac909f868f92",
                                         "details":  {
                                                         "current":  false,
                                                         "ended_on":  "2016-07-13T00:00:00+00:00",
                                                         "started_on":  "2015-05-08T00:00:00+00:00"
                                                     },
                                         "document_type":  "government",
                                         "links":  {

                                                   },
                                         "locale":  "en",
                                         "title":  "2015 to 2016 Cameron Conservative government",
                                         "web_url":  "https://www.gov.uk/government/2015-conservative-government"
                                     }
                                 ],
                  "organisations":  [
                                        {
                                            "analytics_identifier":  "EA63",
                                            "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                            "details":  {
                                                            "acronym":  "MHRA",
                                                            "brand":  "department-of-health",
                                                            "default_news_image":  null,
                                                            "logo":  {
                                                                         "crest":  "single-identity",
                                                                         "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                     },
                                                            "organisation_govuk_status":  {
                                                                                              "status":  "live",
                                                                                              "updated_at":  null,
                                                                                              "url":  null
                                                                                          }
                                                        },
                                            "document_type":  "organisation",
                                            "links":  {

                                                      },
                                            "locale":  "en",
                                            "schema_name":  "organisation",
                                            "title":  "Medicines and Healthcare products Regulatory Agency",
                                            "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                            "withdrawn":  false
                                        }
                                    ],
                  "original_primary_publishing_organisation":  [
                                                                   {
                                                                       "analytics_identifier":  "EA63",
                                                                       "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                                       "details":  {
                                                                                       "acronym":  "MHRA",
                                                                                       "brand":  "department-of-health",
                                                                                       "default_news_image":  null,
                                                                                       "logo":  {
                                                                                                    "crest":  "single-identity",
                                                                                                    "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                                },
                                                                                       "organisation_govuk_status":  {
                                                                                                                         "status":  "live",
                                                                                                                         "updated_at":  null,
                                                                                                                         "url":  null
                                                                                                                     }
                                                                                   },
                                                                       "document_type":  "organisation",
                                                                       "links":  {

                                                                                 },
                                                                       "locale":  "en",
                                                                       "schema_name":  "organisation",
                                                                       "title":  "Medicines and Healthcare products Regulatory Agency",
                                                                       "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                                       "withdrawn":  false
                                                                   }
                                                               ],
                  "primary_publishing_organisation":  [
                                                          {
                                                              "analytics_identifier":  "EA63",
                                                              "api_path":  "/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "api_url":  "https://www.gov.uk/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "base_path":  "/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "content_id":  "240f72bd-9a4d-4f39-94d9-77235cadde8e",
                                                              "details":  {
                                                                              "acronym":  "MHRA",
                                                                              "brand":  "department-of-health",
                                                                              "default_news_image":  null,
                                                                              "logo":  {
                                                                                           "crest":  "single-identity",
                                                                                           "formatted_title":  "Medicines \u0026amp; Healthcare products\u003cbr/\u003eRegulatory Agency"
                                                                                       },
                                                                              "organisation_govuk_status":  {
                                                                                                                "status":  "live",
                                                                                                                "updated_at":  null,
                                                                                                                "url":  null
                                                                                                            }
                                                                          },
                                                              "document_type":  "organisation",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "schema_name":  "organisation",
                                                              "title":  "Medicines and Healthcare products Regulatory Agency",
                                                              "web_url":  "https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "suggested_ordered_related_items":  [
                                                          {
                                                              "api_path":  "/api/content/export-health-certificates/export-zoo-rodents-to-israel-certificate-7835",
                                                              "api_url":  "https://www.gov.uk/api/content/export-health-certificates/export-zoo-rodents-to-israel-certificate-7835",
                                                              "base_path":  "/export-health-certificates/export-zoo-rodents-to-israel-certificate-7835",
                                                              "content_id":  "89c3459d-c972-4f11-a644-e042d015a062",
                                                              "document_type":  "export_health_certificate",
                                                              "links":  {

                                                                        },
                                                              "locale":  "en",
                                                              "public_updated_at":  "2022-11-15T17:13:40Z",
                                                              "schema_name":  "specialist_document",
                                                              "title":  "Export zoo rodents to Israel: certificate 7835 ",
                                                              "web_url":  "https://www.gov.uk/export-health-certificates/export-zoo-rodents-to-israel-certificate-7835",
                                                              "withdrawn":  false
                                                          }
                                                      ],
                  "taxons":  [
                                 {
                                     "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "base_path":  "/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "content_id":  "49f5ab15-d6fe-4a8e-8e56-44878798e7d6",
                                     "details":  {
                                                     "internal_name":  "Vigilance, safety alerts and guidance [T]",
                                                     "notes_for_editors":  "",
                                                     "visible_to_departmental_editors":  false
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "api_url":  "https://www.gov.uk/api/content/health-and-social-care/medicines-medical-devices-blood",
                                                                             "base_path":  "/health-and-social-care/medicines-medical-devices-blood",
                                                                             "content_id":  "cebc01ee-f70a-4397-a552-622e10b62508",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Medicines and medical devices [T] (level 2, health theme)",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  false
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "parent_taxons":  [
                                                                                                                 {
                                                                                                                     "api_path":  "/api/content/health-and-social-care",
                                                                                                                     "api_url":  "https://www.gov.uk/api/content/health-and-social-care",
                                                                                                                     "base_path":  "/health-and-social-care",
                                                                                                                     "content_id":  "8124ead8-8ebc-4faf-88ad-dd5cbcc92ba8",
                                                                                                                     "description":  "",
                                                                                                                     "details":  {
                                                                                                                                     "internal_name":  "Health and social care",
                                                                                                                                     "notes_for_editors":  "",
                                                                                                                                     "visible_to_departmental_editors":  true
                                                                                                                                 },
                                                                                                                     "document_type":  "taxon",
                                                                                                                     "links":  {
                                                                                                                                   "root_taxon":  ""
                                                                                                                               },
                                                                                                                     "locale":  "en",
                                                                                                                     "phase":  "live",
                                                                                                                     "public_updated_at":  "2018-09-16T20:30:51Z",
                                                                                                                     "schema_name":  "taxon",
                                                                                                                     "title":  "Health and social care",
                                                                                                                     "web_url":  "https://www.gov.uk/health-and-social-care",
                                                                                                                     "withdrawn":  false
                                                                                                                 }
                                                                                                             ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2019-02-06T16:16:55Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Medicines, medical devices",
                                                                             "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2018-08-22T12:56:18Z",
                                     "schema_name":  "taxon",
                                     "title":  "Vigilance, safety alerts and guidance",
                                     "web_url":  "https://www.gov.uk/health-and-social-care/medicines-medical-devices-blood-vigilance-safety-alerts",
                                     "withdrawn":  false
                                 },
                                 {
                                     "api_path":  "/api/content/government/brexit",
                                     "api_url":  "https://www.gov.uk/api/content/government/brexit",
                                     "base_path":  "/government/brexit",
                                     "content_id":  "d6c2de5d-ef90-45d1-82d4-5f2438369eea",
                                     "description":  "Find out how new Brexit rules apply to things like travel and doing business with Europe.",
                                     "details":  {
                                                     "internal_name":  "Brexit",
                                                     "notes_for_editors":  "",
                                                     "url_override":  "/government/collections/brexit-guidance",
                                                     "visible_to_departmental_editors":  true
                                                 },
                                     "document_type":  "taxon",
                                     "links":  {
                                                   "parent_taxons":  [
                                                                         {
                                                                             "api_path":  "/api/content/government/all",
                                                                             "api_url":  "https://www.gov.uk/api/content/government/all",
                                                                             "base_path":  "/government/all",
                                                                             "content_id":  "e48ab80a-de80-4e83-bf59-26316856a5f9",
                                                                             "description":  "",
                                                                             "details":  {
                                                                                             "internal_name":  "Government",
                                                                                             "notes_for_editors":  "",
                                                                                             "visible_to_departmental_editors":  true
                                                                                         },
                                                                             "document_type":  "taxon",
                                                                             "links":  {
                                                                                           "root_taxon":  [
                                                                                                              {
                                                                                                                  "api_path":  "/api/content/",
                                                                                                                  "api_url":  "https://www.gov.uk/api/content/",
                                                                                                                  "base_path":  "/",
                                                                                                                  "content_id":  "f3bbdec2-0e62-4520-a7fd-6ffd5d36e03a",
                                                                                                                  "document_type":  "homepage",
                                                                                                                  "links":  {

                                                                                                                            },
                                                                                                                  "locale":  "en",
                                                                                                                  "public_updated_at":  "2023-06-28T09:32:34Z",
                                                                                                                  "schema_name":  "homepage",
                                                                                                                  "title":  "GOV.UK homepage",
                                                                                                                  "web_url":  "https://www.gov.uk/",
                                                                                                                  "withdrawn":  false
                                                                                                              }
                                                                                                          ]
                                                                                       },
                                                                             "locale":  "en",
                                                                             "phase":  "live",
                                                                             "public_updated_at":  "2018-09-16T20:29:39Z",
                                                                             "schema_name":  "taxon",
                                                                             "title":  "Government",
                                                                             "web_url":  "https://www.gov.uk/government/all",
                                                                             "withdrawn":  false
                                                                         }
                                                                     ]
                                               },
                                     "locale":  "en",
                                     "phase":  "live",
                                     "public_updated_at":  "2024-11-14T17:47:34Z",
                                     "schema_name":  "taxon",
                                     "title":  "Brexit",
                                     "web_url":  "https://www.gov.uk/government/brexit",
                                     "withdrawn":  false
                                 }
                             ]
              },
    "locale":  "en",
    "phase":  "live",
    "public_updated_at":  "2019-10-09T16:11:01+01:00",
    "publishing_app":  "whitehall",
    "publishing_request_id":  "21-1713893569.860-10.13.28.206-628",
    "publishing_scheduled_at":  null,
    "rendering_app":  "government-frontend",
    "scheduled_publishing_delay_seconds":  null,
    "schema_name":  "detailed_guide",
    "title":  "Completed Paediatric Studies - submission, processing and assessment in a no-deal Brexit",
    "updated_at":  "2024-11-14T17:48:45+00:00",
    "withdrawn_notice":  {
                             "explanation":  "\u003cdiv class=\"govspeak\"\u003e\u003cp\u003eFor current information on Completed Paediatric Studies see \u003ca href=\"https://www.gov.uk/government/publications/legal-requirements-for-childrens-medicines\" class=\"govuk-link\"\u003eLegal requirements for children’s medicines\u003c/a\u003e\u003c/p\u003e\n\u003c/div\u003e",
                             "withdrawn_at":  "2020-02-24T11:42:05Z"
                         }
}
